Atriance
About Nelarabine
Nelarabine or Atriance is a cancer medication that is used to treat T-cell acute lymphoblastic leukemia (T-ALL) or T-cell lymphoblastic lymphoma (T-LBL). T-lymphoblasts (a kind of immature white blood cell) grow excessively in certain cancers. T-ALL bad cells are mostly found in the blood and bone marrow, whereas T-LBL abnormal cells are primarily found in the lymphatic system (lymph nodes or the thymus gland). Atriance is used when at least two forms of chemotherapy have failed to work or have ceased working.
Strength
250 mg/50 mL (5 mg/mL) vial
Recommended Dosage:
The recommended dosage for Nelarabine is:
Adult dose: 1,500 mg/m², pediatric dose: 650 mg/m², repeated every 21 days.
Important: If patients experience any adverse reactions from the Nelarabine treatment, they must consult their treating doctor.
Warnings & Precautions
- There have been reports of severe neurologic responses. Keep an eye out for signs and symptoms of neurotoxicity.
- Complete blood counts, including platelets, should be checked on a regular basis (Hematologic reactions).
- If delivered to a pregnant woman, fetal damage may occur (Embryo-fetal Toxicity). Women should avoid becoming pregnant while using Antriance.
Common Nelarabine Side Effects
Adults:
- Anemia
- Thrombocytopenia
- Neutropenia
- Nausea
- Diarrhea
- Vomiting
- Constipation
- Fatigue
- Pyrexia
- Cough
- Dyspnea
Pediatric:
- Anemia
- Neutropenia
- Thrombocytopenia
- Leukopenia
Storage and Handling
To protect them from light, store the vials at 25ºC. Excursions are permitted between 15ºC to 30ºC.
We follow a four-step process to procure the medicines:
- Enquiry about the medicines: You submit a request for information about the medications you require using our portal, and we process your data. Within 24 hours, a member of our Named Access Program Support will get in touch with you and provide you with all the assistance you need.
- Verification Process: As we assist patients in finding medications that are not yet approved and readily available in their home countries, Sansfro must confirm the availability and approval of the medicines they need. We also check the patient’s prescription and medical information.
- Sourcing the Medicine: After the verification process has been successfully completed, our staff will contact our vast network of suppliers to find your medicine. Following the process, our team gets the best rates of the medicines for you and ensures processing.
- Safe Delivery: We will set up the consignment’s safe delivery after the final quote is approved. Additionally, our logistics experts can help you track your consignment. The Named Access Program industry has a large number of unauthorized channels. To provide the medications safely and legally, we do so by adhering to the Standard Operating Procedures.
When importing medication, we will need the following documents from the patient:
- A valid prescription copy.
- An identity proof document.
- Details of the attending healthcare professional.
- A current address.
Once we have all these documents, the Sansfro team will initiate the application process for an import license. This license is essential to ensure that we can obtain the necessary medication once it receives government approval.
No news found.
About Sansfro
Sansfro is committed to bridging the healthcare gap. Our purpose is to bring hope and healing to patients suffering from rare diseases by linking them with life-saving treatments through our Named Patient Program. Join us in our quest for a better and healthier world.
Know More...FAQ'S
How does Nelarabine work?
Atriance or Nelarabine is a chemotherapeutic treatment that inhibits cancer cell growth and division, hence slowing or stopping the progression of leukemia.
How is Nelarabine administered?
Nelarabine is often given as an intravenous infusion, which means it is injected directly into a vein by a medical expert.
What is Nelarabine used for?
Nelarabine is used to treat individuals with T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) who have not responded to previous therapies or have had disease recurrence.
What are the common Nelerabine side effects?
Nausea, vomiting, diarrhea, headache, exhaustion, low blood cell counts (anemia, neutropenia, thrombocytopenia), and an increased risk of infection are common adverse effects of Atriance.
How other leukemia treatments are different from Nelarabine treatment?
The indications for Atriance are T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL). It works by selectively targeting T-cells, a kind of immune cell that can become cancerous under these conditions.
Is Atriance appropriate for all T-cell leukemia patients?
Atriance is recommended by healthcare professionals depending on the medical history of the specific patient. It may not be appropriate for all patients, and whether or not to use Atriance is determined by criteria such as illness stage and medical history.
How often to administer Nelarabine?
The Nelarabine or Atriance dosage schedule may vary depending on the individual treatment plan and the patient’s response to the medicine. It is necessary to follow the dose directions as prescribed by the doctor.
IIs Atriance accessible in every country?
Due to governmental clearances and healthcare standards, Atriance’s availability may differ per nation. For information relevant to your locality, it is best to contact a healthcare physician or a patient care specialist at Sansfro who can help you with the medicine in your home country.
Can Atriance be used to treat T-cell leukemia?
Nelarabine may help in the treatment of T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) by reducing or preventing cancer cell proliferation.
What is the price of Atriance in India?
Lorbrena price in India depends on the product requirement. Request more details by reaching out to our Patient Support Team at (+91) 93157 05373 or help@sansfro.com
Dr Anchal Aryan
Medical counselor
Patient Stories
Word Wide Delivery:
India, Andorra, Argentina, Australia, Austria, Azerbaijan, Bahrain, Brazil, Bulgaria, Cambodia, Canada, Chile, Colombia, Costa Rica, Croatia, Cyprus, Denmark, Dominican Republic, Estonia, Finland, France, Georgia, Germany, Ghana, Greece, Guatemala, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kenya, Kuwait, Latvia, Lebanon, Libya, Lithuania, Malawi, Mexico, Montenegro, Nepal, Netherlands, New Zealand, Nigeria, Norway, Oman, Pakistan, Paraguay, Peru, Poland, Qatar, Romania, Saudi Arabia, Serbia, Singapore, Slovenia, Spain, Sri Lanka, Sweden, Switzerland, United Arab Emirates, United Kingdom, United States, Venezuela, Zimbabwe, Afghanistan, Albania, Algeria, American Samoa, Angola, Anguilla, Antarctica, etc.